{"hands_on_practices": [{"introduction": "Molecular mimicry begins at the structural level, where a T-cell receptor (TCR) recognizes the three-dimensional shape and chemistry of a peptide-MHC complex. This practice challenges you to apply your knowledge of protein structure to predict cross-reactivity by comparing a viral peptide to potential self-mimics. By analyzing amino acid substitutions at key TCR contact points, you will develop an intuition for what makes two peptides \"look\" the same to a T cell, a foundational skill for understanding autoimmunity.", "problem": "A cytotoxic T cell receptor (TCR) raised against a virus-derived peptide presented by a class I Major Histocompatibility Complex (MHC) molecule is suspected of cross-reacting with a self peptide, leading to molecular mimicry. Consider that class I MHC binding of typical $9$-mer peptides is governed primarily by anchor residues, which fit into defined pockets of the MHC groove (for example, positions $P2$ and $P\\Omega$), while TCR recognition is dominated by the solvent-exposed peptide side chains and backbone topography, especially around central positions (for example, $P4$–$P6$). You are given a virus peptide $V$ and two candidate self peptides $S_1$ and $S_2$. All three peptides share identical anchor residues at $P2$ and $P\\Omega$ and bind in the same register to the same MHC molecule. Their sequences (letters are one-letter amino acid codes) are as follows, with positions labeled $P1$ to $P\\Omega$:\n\nVirus peptide $V$: A L A T R A G I V\n\nSelf peptide $S_1$: A L A T K A G I V\n\nSelf peptide $S_2$: A L A P D G G I V\n\nAssume that the MHC groove constrains the peptide termini and anchors similarly across the three peptides, making the central peptide surface available to the TCR. Using first principles of peptide–MHC–TCR recognition, predict which self peptide is more likely to induce cross-reactivity by the virus-specific TCR and select the best justification.\n\nA. $S_1$, because conservative substitutions at central TCR-exposed positions (for example, $R \\to K$ at $P5$) preserve electrostatics, side-chain volume, and peptide backbone topography, maintaining a similar TCR-facing shape.\n\nB. $S_2$, because introducing larger physicochemical differences at TCR contact positions generally increases immunogenicity and therefore increases the probability of cross-reactive TCR binding.\n\nC. $S_1$ and $S_2$ are equally likely, because identical MHC anchor residues dominate recognition and TCRs primarily read anchor residues rather than central peptide features.\n\nD. Neither $S_1$ nor $S_2$; cross-reactivity requires identical peptide sequences to reproduce the exact three-dimensional interface needed for TCR binding.\n\nE. $S_2$, because bystander activation during infection renders TCR specificity less important, making even poorly matched TCR–peptide–MHC interactions sufficient for autoreactivity.\n\nChoose the single best option.", "solution": "The problem statement will first be subjected to a rigorous validation process.\n\n**Step 1: Extract Givens**\n- A cytotoxic T cell receptor (TCR) is specific for a virus-derived peptide ($V$) presented by a class I Major Histocompatibility Complex (MHC).\n- The TCR may cross-react with a self peptide, a mechanism defined as molecular mimicry.\n- Class I MHC binding for $9$-mer peptides is primarily determined by anchor residues, for example at positions $P2$ and $P\\Omega$.\n- TCR recognition is primarily determined by solvent-exposed peptide side chains and backbone topography, particularly around central positions, for example $P4$–$P6$.\n- The sequences for the virus peptide $V$ and two self peptides, $S_1$ and $S_2$, are provided. All are $9$-mers.\n    - Virus peptide $V$: A-L-A-T-R-A-G-I-V\n    - Self peptide $S_1$: A-L-A-T-K-A-G-I-V\n    - Self peptide $S_2$: A-L-A-P-D-G-G-I-V\n- All three peptides share identical anchor residues at $P2$ (Leucine, $L$) and $P\\Omega$ (Valine, $V$).\n- All three peptides bind in the same register to the same MHC molecule.\n- The MHC groove constrains the peptide termini and anchors similarly for all three peptides.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, as it is based on fundamental and well-established principles of cellular immunology, specifically the structural basis of peptide-MHC-TCR interactions and the mechanism of molecular mimicry. The terminology is precise and standard. The problem is well-posed; it provides all necessary information (peptide sequences, principles of recognition) to deduce a logical conclusion. The setup is self-consistent and does not contain factual errors, contradictions, or unrealistic assumptions. The problem is an objective application of established theory to a specific case.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. A detailed solution will be derived.\n\n**Derivation**\nThe central task is to determine which self peptide, $S_1$ or $S_2$, is more likely to be recognized by a TCR that is specific for the viral peptide $V$. This cross-reactivity, termed molecular mimicry, depends on the structural and chemical similarity between the self peptide-MHC complex and the viral peptide-MHC complex, from the perspective of the TCR.\n\nThe problem states that TCR recognition is dominated by the central, solvent-exposed residues ($P4$–$P6$). Since the anchor residues ($P2$ and $P\\Omega$) are identical for all three peptides ($V$, $S_1$, $S_2$), their binding to the MHC molecule is assumed to be equivalent. This allows us to focus the analysis on the differences at the TCR contact residues.\n\nLet us compare the amino acid sequences of $V$ with $S_1$ and $S_2$, paying close attention to the central region. The positions are numbered from $P1$ to $P9$ ($P\\Omega$).\n\n**Peptide Sequences:**\n- $V$: $P1$ to $P9$: A L A T **R** A G I V\n- $S_1$: $P1$ to $P9$: A L A T **K** A G I V\n- $S_2$: $P1$ to $P9$: A L A **P** **D** **G** G I V\n\n**Analysis of $V$ versus $S_1$:**\nThe sequences of $V$ and $S_1$ are identical at all positions except for $P5$.\n- At $P5$, peptide $V$ has Arginine ($R$) and peptide $S_1$ has Lysine ($K$).\n- This constitutes a substitution: $R \\to K$.\n- Let us examine the physicochemical properties of Arginine and Lysine. Both are basic amino acids, carrying a positive charge at physiological pH. They possess large, flexible aliphatic side chains. This substitution is defined as **conservative**, as it preserves the key physicochemical properties (charge, size, general shape) of the side chain at this critical TCR contact position. Consequently, the surface presented by the $S_1$-MHC complex to the TCR is expected to be highly similar in both topography and electrostatic potential to the surface of the $V$-MHC complex. A high degree of similarity is the prerequisite for molecular mimicry.\n\n**Analysis of $V$ versus $S_2$:**\nThe sequences of $V$ and $S_2$ differ at three central positions: $P4$, $P5$, and $P6$.\n- At $P4$, the substitution is Threonine ($T$) $\\to$ Proline ($P$). Threonine is a polar amino acid. Proline has a unique cyclic side chain that is covalently bonded to the backbone nitrogen, imposing significant conformational rigidity on the peptide backbone. This change is structurally drastic.\n- At $P5$, the substitution is Arginine ($R$) $\\to$ Aspartic Acid ($D$). Arginine is a large, positively charged amino acid. Aspartic Acid is a smaller, negatively charged amino acid. This substitution is **non-conservative** and results in a complete reversal of charge, which dramatically alters the electrostatic interactions with the TCR.\n- At $P6$, the substitution is Alanine ($A$) $\\to$ Glycine ($G$). Alanine has a small methyl side chain, whereas Glycine's side chain is a single hydrogen atom. This substitution increases the conformational flexibility of the peptide backbone.\n\nThe combination of these three non-conservative and structurally significant substitutions in $S_2$ results in a peptide-MHC surface that is fundamentally different from that of the original viral peptide $V$. The altered backbone conformation due to Proline, the inverted charge at a primary contact residue, and different flexibility collectively create a molecular interface that is very unlikely to be recognized by the TCR specific for $V$.\n\n**Conclusion:**\nFor the virus-specific TCR to cross-react with a self peptide, the self peptide must be a structural and chemical mimic of the viral peptide. Peptide $S_1$ is an excellent mimic due to a single, highly conservative substitution at a TCR contact residue. Peptide $S_2$ is a poor mimic due to multiple, non-conservative substitutions that radically alter the peptide's structure and chemistry. Therefore, $S_1$ is significantly more likely to induce cross-reactivity.\n\n**Option-by-Option Analysis**\n\n**A. $S_1$, because conservative substitutions at central TCR-exposed positions (for example, $R \\to K$ at $P5$) preserve electrostatics, side-chain volume, and peptide backbone topography, maintaining a similar TCR-facing shape.**\nThis statement correctly identifies $S_1$ as the more probable cross-reactive peptide. The justification is scientifically sound: the $R \\to K$ substitution is conservative, preserving key physicochemical properties (charge, size) that are critical for TCR recognition. This preservation of structure leads to molecular mimicry.\n**Verdict: Correct.**\n\n**B. $S_2$, because introducing larger physicochemical differences at TCR contact positions generally increases immunogenicity and therefore increases the probability of cross-reactive TCR binding.**\nThis statement is incorrect. While large physicochemical differences might make a peptide more immunogenic (i.e., capable of priming a *new* T cell response), they decrease the probability of it being recognized by a pre-existing TCR specific for a different peptide. Cross-reactivity requires similarity, not difference. This option confuses immunogenicity with cross-reactivity.\n**Verdict: Incorrect.**\n\n**C. $S_1$ and $S_2$ are equally likely, because identical MHC anchor residues dominate recognition and TCRs primarily read anchor residues rather than central peptide features.**\nThis statement is factually incorrect. It contradicts a fundamental principle of immunology provided in the problem statement itself: TCRs recognize the composite surface of the MHC and the centrally located, solvent-exposed peptide residues, not the MHC-buried anchor residues.\n**Verdict: Incorrect.**\n\n**D. Neither $S_1$ nor $S_2$; cross-reactivity requires identical peptide sequences to reproduce the exact three-dimensional interface needed for TCR binding.**\nThis statement is too stringent. The concept of TCR degeneracy, or promiscuity, is well-established. A single TCR can recognize a range of similar, but not identical, peptide-MHC ligands. Requiring absolute sequence identity would invalidate the entire biological phenomenon of molecular mimicry.\n**Verdict: Incorrect.**\n\n**E. $S_2$, because bystander activation during infection renders TCR specificity less important, making even poorly matched TCR–peptide–MHC interactions sufficient for autoreactivity.**\nThis statement introduces a mechanism, bystander activation, that is distinct from molecular mimicry. The problem is explicitly framed around molecular mimicry, which involves a specific TCR clone cross-reacting with two different peptides. Bystander activation is a non-specific mechanism where local inflammation lowers the activation threshold for autoreactive T cells, irrespective of the activating pathogen's antigen. Conflating these two different pathways is a conceptual error. The question is about the cross-reactivity of the *virus-specific TCR*.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2867155"}, {"introduction": "Moving from qualitative assessment to quantitative analysis, this exercise tasks you with creating a scoring model for molecular mimicry [@problem_id:2867155]. You will assign different weights to matches at T-cell receptor (TCR) contact residues versus Major Histocompatibility Complex (MHC) anchor residues, reflecting their distinct roles in T-cell recognition. The practice culminates in using a null statistical model to define a threshold for significant similarity, providing a powerful tool for sifting through sequence data to identify high-risk candidates for cross-reactivity.", "problem": "A clinician suspects that an autoimmune response was triggered by molecular mimicry between a microbial peptide and a self peptide presented by a Major Histocompatibility Complex (MHC) class I allele with anchor residues at positions $2$ and $9$. In MHC class I presentation, anchor residues primarily determine peptide binding to MHC, whereas T cell receptor (TCR) contacts in the central bulge of the peptide primarily determine TCR recognition. Consider the following model for a $9$-mer peptide bound to an MHC class I molecule in which positions $2$ and $9$ are anchors and positions $3$ through $7$ are the dominant TCR-contact residues. Define a weighted similarity score $S$ between a microbial peptide and a self peptide as\n$$\nS \\equiv w_{t}\\,X_{t} + w_{a}\\,X_{a},\n$$\nwhere $X_{t}$ is the number of exact residue matches at the TCR-contact positions $\\{3,4,5,6,7\\}$, $X_{a}$ is the number of exact residue matches at the anchor positions $\\{2,9\\}$, $w_{t} = 2$, and $w_{a} = 1$. Two $9$-mer peptides are given:\n- Self peptide: ALYGFVYLL\n- Microbial peptide: ALFGFVFIL\n\nTasks:\n1) Compute the weighted similarity score $S$ for this peptide pair.\n2) To decide when similarity is unlikely to arise by chance, model unrelated peptide pairs as having independent, identically distributed residues with a uniform amino acid distribution. Under this null model, the per-position exact-match probability is $p = \\frac{1}{20}$. Treat $X_{t} \\sim \\mathrm{Binomial}(n_{t}, p)$ with $n_{t} = 5$ and $X_{a} \\sim \\mathrm{Binomial}(n_{a}, p)$ with $n_{a} = 2$, independent because they refer to disjoint positions. Derive the null mean $\\mu_{S}$ and variance $\\sigma_{S}^{2}$ of $S$, and set a conservative high-risk mimicry threshold\n$$\nT \\equiv \\mu_{S} + 3\\,\\sigma_{S}.\n$$\nCompute $T$ numerically.\n\nExplain the immunological rationale for weighting TCR-contact matches more heavily than anchor matches and for using the three-standard-deviation rule to define a high-risk threshold, in the context of distinguishing molecular mimicry from bystander activation. Report both the computed similarity score and the threshold as two numbers. Round the threshold to $4$ significant figures.", "solution": "The problem is first subjected to validation.\n\nStep 1: Extract Givens.\n- The system under consideration is the interaction between a T-cell receptor (TCR), a peptide, and a Major Histocompatibility Complex (MHC) class I molecule.\n- The peptide is a $9$-mer.\n- Anchor residue positions are $\\{2, 9\\}$.\n- TCR-contact residue positions are $\\{3,4,5,6,7\\}$.\n- A weighted similarity score $S$ is defined as $S \\equiv w_{t}\\,X_{t} + w_{a}\\,X_{a}$.\n- $X_{t}$ is the number of exact amino acid matches at the $n_{t} = 5$ TCR-contact positions.\n- $X_{a}$ is the number of exact amino acid matches at the $n_{a} = 2$ anchor positions.\n- The weights are $w_{t} = 2$ and $w_{a} = 1$.\n- The two peptides for comparison are:\n  - Self peptide: ALYGFVYLL\n  - Microbial peptide: ALFGFVFIL\n- A null model is proposed for random similarity:\n  - Residues are independent and identically distributed (i.i.d.).\n  - The per-position exact-match probability is $p = \\frac{1}{20}$.\n  - $X_{t}$ is modeled as a binomial random variable: $X_{t} \\sim \\mathrm{Binomial}(n_{t}, p)$ with $n_{t} = 5$.\n  - $X_{a}$ is modeled as a binomial random variable: $X_{a} \\sim \\mathrm{Binomial}(n_{a}, p)$ with $n_{a} = 2$.\n  - $X_{t}$ and $X_{a}$ are statistically independent.\n- A high-risk mimicry threshold is defined as $T \\equiv \\mu_{S} + 3\\,\\sigma_{S}$, where $\\mu_{S}$ and $\\sigma_{S}^{2}$ are the mean and variance of $S$ under the null model, respectively.\n- The tasks are: 1) Compute $S$ for the given peptide pair. 2) Derive $\\mu_{S}$ and $\\sigma_{S}^{2}$, then compute $T$ (rounded to $4$ significant figures). 3) Explain the immunological rationale for the weighting scheme and the statistical threshold in the context of distinguishing molecular mimicry from bystander activation.\n\nStep 2: Validate Using Extracted Givens.\n- Scientific Grounding: The problem is a simplified but valid quantitative model of molecular mimicry, a well-established concept in immunology. The roles of anchor and TCR-contact residues are correctly stated. The use of a binomial distribution to model random matches is a standard statistical approach. The problem is scientifically grounded.\n- Well-Posedness: The problem provides all necessary definitions, data, and a clear set of tasks. The model is fully specified, allowing for a unique solution to be calculated.\n- Objectivity: The problem is stated in precise, objective language without subjective claims.\n\nStep 3: Verdict and Action.\nThe problem is valid. It is a well-posed, scientifically grounded problem in quantitative immunology. A complete solution will be provided.\n\nThe first task is to compute the weighted similarity score $S$ for the given pair of peptides. We align the self peptide and microbial peptide and count the number of exact matches at the specified positions.\nSelf peptide:      $A_1 L_2 Y_3 G_4 F_5 V_6 Y_7 L_8 L_9$\nMicrobial peptide: $A_1 L_2 F_3 G_4 F_5 V_6 F_7 I_8 L_9$\n\nThe TCR-contact positions are $\\{3,4,5,6,7\\}$.\n- Position $3$: Y vs. F (no match)\n- Position $4$: G vs. G (match)\n- Position $5$: F vs. F (match)\n- Position $6$: V vs. V (match)\n- Position $7$: Y vs. F (no match)\nThe number of matches at TCR-contact positions is $X_{t} = 3$.\n\nThe anchor positions are $\\{2,9\\}$.\n- Position $2$: L vs. L (match)\n- Position $9$: L vs. L (match)\nThe number of matches at anchor positions is $X_{a} = 2$.\n\nUsing the formula for the weighted similarity score, $S = w_{t}X_{t} + w_{a}X_{a}$:\n$$ S = (2)(3) + (1)(2) = 6 + 2 = 8 $$\n\nThe second task is to characterize the null distribution of $S$ and compute the threshold $T$. Let $S$ be the random variable $S = w_{t}X_{t} + w_{a}X_{a}$, where $X_{t} \\sim \\mathrm{Binomial}(n_{t}, p)$ and $X_{a} \\sim \\mathrm{Binomial}(n_{a}, p)$ are independent. The parameters are $w_{t}=2$, $w_{a}=1$, $n_{t}=5$, $n_{a}=2$, and $p=\\frac{1}{20}$.\n\nWe first derive the mean of $S$, $\\mu_{S}$. Using the linearity of expectation:\n$$ \\mu_{S} = E[S] = E[w_{t}X_{t} + w_{a}X_{a}] = w_{t}E[X_{t}] + w_{a}E[X_{a}] $$\nThe mean of a binomial distribution $\\mathrm{Binomial}(n, p)$ is $np$.\n$$ E[X_{t}] = n_{t}p = 5 \\times \\frac{1}{20} = \\frac{5}{20} = \\frac{1}{4} $$\n$$ E[X_{a}] = n_{a}p = 2 \\times \\frac{1}{20} = \\frac{2}{20} = \\frac{1}{10} $$\nSubstituting these into the expression for $\\mu_{S}$:\n$$ \\mu_{S} = (2)\\left(\\frac{1}{4}\\right) + (1)\\left(\\frac{1}{10}\\right) = \\frac{1}{2} + \\frac{1}{10} = \\frac{5}{10} + \\frac{1}{10} = \\frac{6}{10} = 0.6 $$\n\nNext, we derive the variance of $S$, $\\sigma_{S}^{2}$. Since $X_{t}$ and $X_{a}$ are independent, the variance of their weighted sum is the weighted sum of their variances:\n$$ \\sigma_{S}^{2} = \\mathrm{Var}(S) = \\mathrm{Var}(w_{t}X_{t} + w_{a}X_{a}) = w_{t}^{2}\\mathrm{Var}(X_{t}) + w_{a}^{2}\\mathrm{Var}(X_{a}) $$\nThe variance of a binomial distribution $\\mathrm{Binomial}(n, p)$ is $np(1-p)$.\n$$ 1 - p = 1 - \\frac{1}{20} = \\frac{19}{20} $$\n$$ \\mathrm{Var}(X_{t}) = n_{t}p(1-p) = 5 \\left(\\frac{1}{20}\\right) \\left(\\frac{19}{20}\\right) = \\frac{95}{400} = \\frac{19}{80} $$\n$$ \\mathrm{Var}(X_{a}) = n_{a}p(1-p) = 2 \\left(\\frac{1}{20}\\right) \\left(\\frac{19}{20}\\right) = \\frac{38}{400} = \\frac{19}{200} $$\nSubstituting these into the expression for $\\sigma_{S}^{2}$:\n$$ \\sigma_{S}^{2} = (2)^{2}\\left(\\frac{19}{80}\\right) + (1)^{2}\\left(\\frac{19}{200}\\right) = 4\\left(\\frac{19}{80}\\right) + \\frac{19}{200} = \\frac{19}{20} + \\frac{19}{200} = \\frac{190}{200} + \\frac{19}{200} = \\frac{209}{200} = 1.045 $$\n\nFinally, we compute the threshold $T = \\mu_{S} + 3\\sigma_{S}$.\n$$ \\sigma_{S} = \\sqrt{\\sigma_{S}^{2}} = \\sqrt{1.045} $$\n$$ T = 0.6 + 3\\sqrt{1.045} \\approx 0.6 + 3(1.0222524) \\approx 0.6 + 3.0667572 \\approx 3.6667572 $$\nRounding to $4$ significant figures, we get $T = 3.667$.\n\nThe third task is to explain the immunological rationale.\nThe weighting scheme $w_{t}  w_{a}$ is immunologically justified because molecular mimicry is fundamentally a phenomenon of T-cell cross-reactivity. For a T-cell to be activated, its TCR must physically bind to a peptide-MHC (pMHC) complex with sufficient affinity and duration. This interaction is primarily governed by the peptide residues that are exposed and available for TCR contact—in this model, positions $\\{3,4,5,6,7\\}$. A match at these positions is therefore a strong predictor of shared TCR recognition. In contrast, the anchor residues (positions $\\{2,9\\}$) are buried within the MHC binding groove. Their role is to secure the peptide to the MHC molecule for presentation on the cell surface. While essential for presentation, similarity at anchor positions does not directly imply that the exposed faces of the two different peptides will be recognized by the same TCR. Many peptides with different TCR-contact residues can bind to the same MHC allele via identical anchor residues. Therefore, to model the likelihood of true cross-reactivity, it is logical to assign a higher weight to matches at the TCR-contact interface.\n\nThe threshold $T = \\mu_{S} + 3\\sigma_{S}$ provides a statistically rigorous criterion to distinguish a specific, high-similarity event (indicative of molecular mimicry) from a non-specific or random event. Molecular mimicry is an antigen-specific mechanism where sequence/structural similarity between a foreign peptide and a self-peptide leads to a pathogen-directed immune response being mistakenly targeted at self-tissues. Bystander activation, conversely, is an antigen-independent mechanism. In a highly inflammatory environment, such as during a severe infection, cytokines can non-specifically lower the activation threshold of T-cells, causing self-reactive T-cells that are not specific to the pathogen to become activated and cause tissue damage. The null model describes the distribution of similarity scores $S$ that one would expect to observe between random, unrelated peptide pairs. The threshold $T$, set at three standard deviations above the mean, establishes a cutoff for statistical rarity. If the calculated similarity score $S$ for a given peptide pair exceeds this threshold (i.e., $S  T$), the observed similarity is highly unlikely to have arisen by chance ($p \\approx 0.0013$ under a normal approximation). This provides strong statistical evidence supporting molecular mimicry as the plausible mechanism for autoimmunity. If $S \\le T$, the similarity is not statistically significant, and one cannot rule out that it occurred by chance. In such a scenario, bystander activation would be considered a more likely explanation for any observed autoimmunity, as there is no strong evidence of specific cross-reactivity. This conservative threshold minimizes the rate of false positives, ensuring that only pairs with exceptionally high similarity are flagged as potential candidates for molecular mimicry.\nIn this specific case, the computed score $S=8$ is much greater than the threshold $T=3.667$, strongly suggesting that the similarity between the microbial and self peptides is not coincidental and that molecular mimicry is a very plausible mechanism for the suspected autoimmune response.", "answer": "$$\n\\boxed{\\begin{pmatrix} 8  3.667 \\end{pmatrix}}\n$$", "id": "2867151"}, {"introduction": "A high-risk mimicking peptide [@problem_id:2867151] can only trigger autoimmunity if it is presented at a sufficient density on the cell surface. This problem focuses on the fundamental biophysics of antigen presentation, requiring you to derive the exact equilibrium binding equation for peptide-MHC interactions when ligand and receptor concentrations are comparable. This exercise connects the molecular affinity ($K_D$) to the cellular density of presented antigens, a critical parameter that governs the magnitude of the initial T-cell response and the potential for autoimmune activation.", "problem": "An antigen-presenting cell (APC) processes a microbial peptide that is structurally similar to a host peptide, a scenario relevant to molecular mimicry. In the peptide-loading compartment, Major Histocompatibility Complex (MHC) class II molecules bind peptide according to equilibrium mass-action kinetics. Assume that catalytic editing by HLA-DM yields an equilibrium distribution and that once loaded, peptide–MHC complexes traffic to the surface without further peptide exchange, so that the endosomal equilibrium occupancy fraction propagates to the cell surface. The following experimentally measured parameters are obtained in a microsomal loading assay conducted at steady state for a single microbial peptide species in the presence of an excess of unrelated background peptides that do not bind this MHC:\n- Dissociation constant of the microbial peptide for the MHC, $K_{D} = 1.5 \\times 10^{-7}\\ \\mathrm{M}$.\n- Total peptide concentration in the loading compartment specific to the microbial peptide, $[P]_{\\mathrm{T}} = 2.0 \\times 10^{-6}\\ \\mathrm{M}$.\n- Total MHC concentration available for binding in the loading compartment, $[M]_{\\mathrm{T}} = 2.0 \\times 10^{-7}\\ \\mathrm{M}$.\n- Total number of MHC molecules that reach the plasma membrane per cell over the relevant time window, $N_{\\mathrm{M}} = 1.20 \\times 10^{5}$.\n\nStarting only from the definition of the dissociation constant for a $1:1$ binding reaction and conservation of mass, derive the exact finite-ligand equilibrium expression for the bound complex concentration $[PM]$ and the MHC occupancy fraction $f = [PM]/[M]_{\\mathrm{T}}$ as functions of $K_{D}$, $[P]_{\\mathrm{T}}$, and $[M]_{\\mathrm{T}}$. Then, using the provided numerical values, compute the antigen presentation density on the cell surface for the microbial peptide, defined as $D = f \\times N_{\\mathrm{M}}$, expressed as copies per cell.\n\nBriefly explain how an elevated $D$ for a cross-reactive microbial peptide could mechanistically contribute to bystander activation of autoreactive T cells in the context of molecular mimicry, but do not report this qualitative assessment in your numerical answer.\n\nRound your final numerical answer for $D$ to four significant figures. Express the final value in copies per cell. Percentages, if any, must be expressed as decimals, not with a percentage sign.", "solution": "The problem requires the derivation of an expression for the concentration of the peptide-MHC complex, $[PM]$, at equilibrium, followed by a calculation of the antigen presentation density on the cell surface. The validation of the problem statement confirms that it is scientifically grounded, well-posed, and objective. It is based on fundamental principles of biochemical kinetics and immunology. All necessary data are provided, and the parameters are within physically plausible ranges. We may therefore proceed with the solution.\n\nThe binding of a peptide, $P$, to a Major Histocompatibility Complex (MHC) molecule, $M$, to form a complex, $PM$, is described by the reversible reaction:\n$$ P + M \\rightleftharpoons PM $$\nAt equilibrium, the relationship between the concentrations of the free reactants and the product is defined by the dissociation constant, $K_{D}$:\n$$ K_{D} = \\frac{[P][M]}{[PM]} $$\nwhere $[P]$ and $[M]$ are the equilibrium concentrations of the free peptide and free MHC, respectively, and $[PM]$ is the equilibrium concentration of the bound complex.\n\nThe system is closed, so the total concentrations of peptide, $[P]_{\\mathrm{T}}$, and MHC, $[M]_{\\mathrm{T}}$, are conserved. This is expressed through the law of mass conservation:\n$$ [P]_{\\mathrm{T}} = [P] + [PM] $$\n$$ [M]_{\\mathrm{T}} = [M] + [PM] $$\nFrom these conservation equations, we can express the free concentrations in terms of the total concentrations and the bound complex concentration:\n$$ [P] = [P]_{\\mathrm{T}} - [PM] $$\n$$ [M] = [M]_{\\mathrm{T}} - [PM] $$\nSubstituting these expressions for $[P]$ and $[M]$ into the definition of $K_{D}$ yields an equation solely in terms of $[PM]$ and the known total concentrations:\n$$ K_{D} = \\frac{([P]_{\\mathrm{T}} - [PM])([M]_{\\mathrm{T}} - [PM])}{[PM]} $$\nTo solve for $[PM]$, we rearrange this equation into a standard quadratic form, $ax^2 + bx + c = 0$, where $x = [PM]$.\n$$ K_{D}[PM] = ([P]_{\\mathrm{T}} - [PM])([M]_{\\mathrm{T}} - [PM]) $$\n$$ K_{D}[PM] = [P]_{\\mathrm{T}}[M]_{\\mathrm{T}} - [P]_{\\mathrm{T}}[PM] - [M]_{\\mathrm{T}}[PM] + [PM]^2 $$\n$$ [PM]^2 - ([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})[PM] + [P]_{\\mathrm{T}}[M]_{\\mathrm{T}} = 0 $$\nThis is the exact quadratic equation for the equilibrium concentration of the bound complex, $[PM]$. The solution is given by the quadratic formula:\n$$ [PM] = \\frac{-b \\pm \\sqrt{b^2 - 4ac}}{2a} $$\nwhere $a = 1$, $b = -([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})$, and $c = [P]_{\\mathrm{T}}[M]_{\\mathrm{T}}$.\nSubstituting these coefficients, we obtain:\n$$ [PM] = \\frac{([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D}) \\pm \\sqrt{([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})^2 - 4[P]_{\\mathrm{T}}[M]_{\\mathrm{T}}}}{2} $$\nWe must select the physically realistic root. The concentration of the complex, $[PM]$, cannot exceed either of the total concentrations, $[P]_{\\mathrm{T}}$ or $[M]_{\\mathrm{T}}$. Let us examine the positive root. The term $([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})$ is strictly greater than $\\sqrt{([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})^2 - 4[P]_{\\mathrm{T}}[M]_{\\mathrm{T}}}$. However, the sum in the numerator could lead to $[PM]  \\min([P]_{\\mathrm{T}}, [M]_{\\mathrm{T}})$. For instance, in the limit of tight binding ($K_{D} \\to 0$), the numerator with the positive root approximates to $([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}}) + |[P]_{\\mathrm{T}} - [M]_{\\mathrm{T}}|$. If $[P]_{\\mathrm{T}}  [M]_{\\mathrm{T}}$, this becomes $2[P]_{\\mathrm{T}}$, yielding $[PM] \\approx [P]_{\\mathrm{T}}$, which violates the constraint $[PM] \\leq [M]_{\\mathrm{T}}$. The negative root, in the same limit, yields $([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}}) - |[P]_{\\mathrm{T}} - [M]_{\\mathrm{T}}|$, which correctly gives $2[M]_{\\mathrm{T}}$ if $[P]_{\\mathrm{T}}  [M]_{\\mathrm{T}}$ (so $[PM] \\approx [M]_{\\mathrm{T}}$) and $2[P]_{\\mathrm{T}}$ if $[M]_{\\mathrm{T}}  [P]_{\\mathrm{T}}$ (so $[PM] \\approx [P]_{\\mathrm{T}}$). In both cases, the negative root correctly resolves to $[PM] \\approx \\min([P]_{\\mathrm{T}}, [M]_{\\mathrm{T}})$. Therefore, the physically correct solution is:\n$$ [PM] = \\frac{1}{2}\\left( ([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D}) - \\sqrt{([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})^2 - 4[P]_{\\mathrm{T}}[M]_{\\mathrm{T}}} \\right) $$\nThe MHC occupancy fraction, $f$, is defined as the fraction of total MHC that is bound to peptide:\n$$ f = \\frac{[PM]}{[M]_{\\mathrm{T}}} $$\nSubstituting the expression for $[PM]$ gives the final form for $f$:\n$$ f = \\frac{1}{2[M]_{\\mathrm{T}}}\\left( ([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D}) - \\sqrt{([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})^2 - 4[P]_{\\mathrm{T}}[M]_{\\mathrm{T}}} \\right) $$\n\nNow we compute the numerical value using the provided parameters:\n$K_{D} = 1.5 \\times 10^{-7}\\ \\mathrm{M}$\n$[P]_{\\mathrm{T}} = 2.0 \\times 10^{-6}\\ \\mathrm{M}$\n$[M]_{\\mathrm{T}} = 2.0 \\times 10^{-7}\\ \\mathrm{M}$\n$N_{\\mathrm{M}} = 1.20 \\times 10^{5}$\n\nFirst, we calculate the terms required for the $[PM]$ expression:\n$$ [P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D} = (2.0 \\times 10^{-6}) + (0.2 \\times 10^{-6}) + (0.15 \\times 10^{-6}) = 2.35 \\times 10^{-6}\\ \\mathrm{M} $$\n$$ 4[P]_{\\mathrm{T}}[M]_{\\mathrm{T}} = 4(2.0 \\times 10^{-6})(2.0 \\times 10^{-7}) = 1.6 \\times 10^{-12}\\ \\mathrm{M}^2 $$\n$$ ([P]_{\\mathrm{T}} + [M]_{\\mathrm{T}} + K_{D})^2 = (2.35 \\times 10^{-6})^2 = 5.5225 \\times 10^{-12}\\ \\mathrm{M}^2 $$\nThe term under the square root is:\n$$ \\sqrt{5.5225 \\times 10^{-12} - 1.6 \\times 10^{-12}} = \\sqrt{3.9225 \\times 10^{-12}} = 1.98053... \\times 10^{-6}\\ \\mathrm{M} $$\nNow, we calculate $[PM]$:\n$$ [PM] = \\frac{1}{2}(2.35 \\times 10^{-6} - 1.98053... \\times 10^{-6}) = \\frac{1}{2}(0.36946... \\times 10^{-6}) = 1.8473... \\times 10^{-7}\\ \\mathrm{M} $$\nNext, we calculate the occupancy fraction $f$:\n$$ f = \\frac{[PM]}{[M]_{\\mathrm{T}}} = \\frac{1.8473... \\times 10^{-7}\\ \\mathrm{M}}{2.0 \\times 10^{-7}\\ \\mathrm{M}} = 0.92367... $$\nFinally, we compute the antigen presentation density, $D$, which is the total number of microbial peptide-MHC complexes on the cell surface:\n$$ D = f \\times N_{\\mathrm{M}} = (0.92367...) \\times (1.20 \\times 10^{5}) = 110841.0... $$\nRounding to four significant figures as required gives:\n$$ D \\approx 1.108 \\times 10^{5} \\text{ copies per cell} $$\n\nThe qualitative part of the question asks for an explanation of how an elevated density $D$ of a cross-reactive microbial peptide can contribute to bystander activation of autoreactive T cells.\nAn elevated presentation density $D$ of a microbial peptide that mimics a self-peptide is a critical initiating factor for autoimmunity. This high density ensures a strong activation signal to any T cells whose T-cell receptors (TCRs) can bind this microbial peptide-MHC (pMHC) complex. In the scenario of molecular mimicry, a subset of these responding T cells are autoreactive clones whose TCRs cross-react, recognizing both the foreign microbial peptide and a structurally similar self-peptide. The robust activation of these cross-reactive T cells initiates a potent inflammatory cascade within the local tissue environment, characterized by the secretion of pro-inflammatory cytokines such as interferon-$\\gamma$ and interleukin-2.\nThis intense inflammatory milieu is the direct link to bystander activation. The high concentration of cytokines and the up-regulation of co-stimulatory molecules on antigen-presenting cells (APCs) dramatically lower the activation threshold for all T cells in the vicinity. Consequently, other autoreactive T-cell clones—which are specific for different self-peptides and are not cross-reactive with the initial microbial antigen—can become activated upon encountering their cognate self-pMHC, even if it is presented at a low, otherwise non-stimulatory density. This phenomenon, where the inflammatory context provided by a primary immune response enables the activation of unrelated autoreactive lymphocytes, is bystander activation. Thus, a high density $D$ of a mimicking peptide serves as the trigger that not only directly activates cross-reactive T cells but also creates the inflammatory conditions necessary for the bystander activation of a broader spectrum of autoreactive T cells, precipitating a more widespread autoimmune attack.", "answer": "$$\\boxed{1.108 \\times 10^{5}}$$", "id": "2867150"}]}